Sundown Syndrome · What It Is, Causes, Signs and Symptoms, Diagnosis, and More

Published: Nov 04, 2025
Author: Emily Miao, PharmD, MD
Editor: Alyssa Haag, MD
Editor: Ian Mannarino, MD, MBA
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Editor: Anna Hernández, MD
Illustrator: Jessica Reynolds, MS
7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews
Watch quick, visual videos
Practice with Qbank-style questions
Use AI to explain, quiz, and review
Study anytime with the mobile app
Start free trial

No credit card · Cancel anytime

What is sundown syndrome?

Sundown syndrome is a complex phenomenon that refers to the emergence or worsening of neuropsychiatric symptoms in people with dementia (e.g., Alzheimer disease), in the late afternoon or towards the end of the day. These neuropsychiatric symptoms can include confusion, agitation, anxiety, and mood swings, and are associated with adverse clinical outcomes such as increased risk of hospitalization, rapid worsening of cognition, and caregiver burden. 

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

What causes sundown syndrome?

The exact mechanisms of sundown syndrome are poorly understood, however, it is thought to be a complex interplay between various factors including neurobiological and physiological disruptions, underlying medical conditions, environmental factors, and medications.  

In terms of neurobiological factors, alterations in neurotransmitters such as acetylcholine (i.e., which is abnormally low in dementia) and melatonin levels may influence the individual’s circadian rhythm and alter their body clock. These neurotransmitter imbalances and alterations may contribute to sundowning.  

Unmet physiological needs, like hunger, fatigue, or needing the bathroom may not be expressed clearly, leading to agitation which could exacerbate sundown syndrome. Underlying medical conditions like insomnia and uncontrolled pain may also contribute to irritability and agitation. As natural light fades, visual perception can worsen, creating misinterpretations of surroundings and increasing confusion or fear.  

Additionally, other environmental factors like overstimulation during the day or complete boredom could make someone more agitated in the evening. Some individuals may pick up on staff or family caregiver changes in the evening, which can increase anxiety or insecurity.    

Finally, some of the medications used to manage symptoms like anxiety, agitation, depression, psychosis, or sleep problems can unintentionally worsen sundowning or other behavioral symptoms, especially if not used carefully. These medications include antipsychotics (e.g., haloperidol), anticholinergics (e.g., donepezil, diphenhydramine), and benzodiazepines (e.g., diazepam, lorazepam).  

What are the signs and symptoms of sundown syndrome?

Signs of sundowning may vary between individuals but typically include neuropsychiatric symptoms that worsen during the later times of the day. Individuals experiencing sundowning may exhibit heightened confusion, disorientation, inability to remain calm (e.g., agitation, restlessness), mood symptoms (e.g., withdrawn affect, anxiety, irritability, suspiciousness), hallucinations or delusions, and sleep problems (e.g., difficulty sleeping at night). These signs and symptoms may range in severity and may not be present daily. 

How is sundown syndrome diagnosed?

Diagnosis of sundown syndrome is clinical and begins with a thorough review of symptoms and medical history that is often obtained from family members or caregivers depending on the stage of dementia. This involves careful observation and documentation of the individual’s behaviors throughout the day, with a focus on the late afternoon, evening, and night hours. Cognitive questionnaires (e.g., mini-mental state exam or MMSE) may be administered to evaluate the individual’s cognitive function and to diagnose or assess the progression of dementia. Other diagnoses may present with similar symptoms, such as depression and sleep disorders, therefore a pertinent history related to mood symptoms, changes in habits and routines, and sleep patterns should be elicited.  

While routine laboratory tests are not required for diagnosis, they can help exclude underlying conditions that may mimic sundowning behaviors, such as a urinalysis to exclude urinary tract infections. If the individual is presenting for the first time with sundowning behaviors, a dementia work-up can be pursued to exclude reversible causes (e.g., vitamin B12, thyroid function tests, HIV screening). Neuroimaging (e.g., computed tomography or magnetic resonance imaging) may not be required but can be helpful when excluding neurologic conditions like a stroke or a brain tumor. The diagnosis is made when a temporal pattern of characteristic behaviors is established in conjunction with a known history of dementia and secondary causes (e.g., infection, medications, brain lesions) are excluded.  

How is sundown syndrome treated?

There is currently no cure for sundown syndrome and treatment consists of a multidisciplinary approach that is aimed at slowing the progression of dementia, reducing neuropsychiatric symptoms, and improving the individual’s quality of life.   

Individuals diagnosed with dementia can be initiated on medications aimed at slowing the progression of the disease. Early and middle-stage dementia can initially be treated with anticholinergics (e.g., donepezil), while NMDA-receptor antagonists (e.g., memantine) may be indicated for more advanced stages. Measures should be taken to reduce polypharmacy and to titrate dementia medication doses appropriately, as they may also cause side effects that could exacerbate symptoms of sundowning 

Non-pharmacological ways to prevent sundowning include maintaining a consistent daily routine and sleep schedule, as well as avoiding naps during the day. Exposure to natural light during the mornings can help support healthy sleep-wake cycles, whereas creating a calm and familiar environment in the evenings may reduce anxiety. Activities like listening to soothing music, gentle stretching, watching familiar TV shows, or spending quiet time with a familiar caregiver can also reduce restlessness.  

What are the most important facts to know about sundown syndrome?

Sundown syndrome, or sundowning, is a common pattern in people with dementia where they become more confused, agitated, or anxious in the late afternoon or evening. It is likely caused by a mix of neurobiological changes, a disrupted body clock, fatigue, and low lighting, which can all make it harder for the brain to process the environment. Symptoms can include restlessness, mood swings, wandering, and trouble sleeping. While there’s no cure, it can often be managed by keeping a regular routine, using calming activities in the afternoon, and avoiding triggers like overstimulation or long naps. Medications are sometimes used but can make symptoms worse, so non-drug approaches are usually the safest and most effective first step. 

Key Takeaways

Definition 
 

Sundown syndrome refers to the emergence or worsening of neuropsychiatric symptoms in people with dementia (e.g., Alzheimer disease) in the late afternoon or towards the end of the day.  

Causes 
 

- Neurobiological factors influencing circadian rhythm (altered neurotransmitters and melatonin levels) 

- Unmet physiological needs (hunger, fatigue, needing the bathroom) → agitation  

- Underlying medical conditions (insomnia, uncontrolled pain)  

- Worsened visual perception as light fades → misinterpretations of surroundings  

- Environmental factors: overstimulation during the day, boredom, staff or family caregiver changes  

- Medications: antipsychotics, anticholinergics, benzodiazepines 

Signs and Symptoms 

- Confusion 

- Disorientation  

- Agitation, restlessness 

- Mood symptoms  

- Hallucinations or delusions  

- Sleep problems  

Diagnosis 

- Diagnosis: temporal pattern of characteristic behaviors + history of dementia + exclusion of secondary causes  

- Review of symptoms and medical history  

     - Documentation of behaviors throughout the day  

     - Cognitive questionnaires  

     - History of mood symptoms, changes in habits and routines (rule out depression and sleep disorders 

     - Dementia work-up 

- Laboratory tests: to rule out mimicking or triggering underlying conditions  

- Neuroimaging (exclude neurological conditions 

Treatment 

- Multidisciplinary approach to slow down progression of dementia and reduce neuropsychiatric symptoms  

- Medications for early and middle-stage dementia:  

- Anticholinergics  

- NMDA-receptor antagonists (e.g., memantine)  

- Reduce polypharmacy and properly titrate doses 

- Non-pharmacological treatment:  

     - Consistent daily routine and sleep schedule  

     - Avoid naps  

     - Exposure to natural light in the morning  

     - Calm and familiar environment in the evenings  

     - Soothing music, gentle stretching, watching familiar TV shows, spending quiet time with familiar caregiver 

Students say Osmosis is 100% worth it

Because Osmosis saves them time. Lowers stress. And actually helps them remember when it counts.

I used Osmosis to prepare for my first medical school licensing exam! Super helpful and interactive for people who may not do great with just pages of text info!

Cecilia Ruiz

Cecilia Ruiz

MD student

Sayan Misra

I have used Osmosis for about four years. Best thing I have ever used for my medical studies.

Sayan Misra

Sayan Misra

Med student

Osmosis videos are superior because they define simple concepts, tell a story with a clear progression, and provide context.

Jay Pate

Jay Pate

Dental student

References


Boronat AC, Ferreira-Maia AP, Wang YP. Sundown syndrome in older persons: A scoping review. J Am Med Dir Assoc. 2019;20(6):664-671.e5. doi:10.1016/j.jamda.2019.03.001 


Huang SF, Wang BY, Liao JY. Experiences of person-centered care for sundown syndrome among nurses and nurse aides in dementia special care units: a qualitative study. BMC Nurs. 2023;22(1):435. doi:10.1186/s12912-023-01598-x 


Reimus M, Siemiński M. Sundowning syndrome in dementia: Mechanisms, diagnosis, and treatment. J Clin Med. 2025;14(4). doi:10.3390/jcm14041158 


Safiri S, Ghaffari Jolfayi A, Fazlollahi A, et al. Alzheimer’s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Front Med (Lausanne). 2024;11:1474043. doi:10.3389/fmed.2024.1474043